Last Round
Series A
Feb 1, 2023
Total Funding Raised
$48M
Company Overview
Proviva Therapeutics is a biotechnology company that develops a pharmaceutical technology platform intended for anti-tumor immunity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
cancer immunotherapyimmuno-oncologyprodrug technologycytokine prodrugfusion proteintumor microenvironment activationcytokine therapypro-cytokineI-Ocheckpoint inhibitorPD-1/IL-2 fusion proteinclinical stage biotecheffector cell activationbiopharmaceuticals
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proviva Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Proviva Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 1, 2023 | ||||
| Series A Extension | Dec 1, 2022 |
Proviva Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Series A Extension |
| HongShan | Series A Extension |
| Ennovation Ventures | Series A |
| HongShan | Series A Extension |
Proviva Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Proviva Therapeutics's valuation, stock price, and market status.